Featured Article
Off-Label Marketing Puts Patients at Risk
Off-Label Marketing Puts Patients at Risk

Valuing money over patient health, pharmaceutical manufacturers are typically driven financially. “Off-label” refers to uses which have not yet received approval or proper testing by the U.S. Food and Drug Administration (FDA). Unfortunately, Big Pharma has been promoting ...

Read More

Blog posts in June, 2017

  • Doctors are Fatally Overprescribing Opioids

    As of 2012, the Centers for Disease Control and Prevention (CDC) has officially declared that prescription drug abuse in the United States as an ...

    View More
  • Patient Safety Can Lower Healthcare Costs

    Healthcare costs have been on the rise, and this important issue has led to a number of different lawmakers suggesting different methods of trying to ...

    View More
  • Medical Malpractice Reforms Could Hurt Patients

    Congress seems ready to move along medical malpractice reforms which put earning a profit over the safety of patients. H.R. 1215 – also known as ...

    View More
  • Fentanyl Prescriptions Can Be Medical Malpractice

    Fentanyl is a potent narcotic drug that is similar to morphine, but 80 to 100 times stronger. It is a synthetic opioid, often used to treat severe or ...

    View More

Contact Us Today!

All Consultations are Free and Confidential
    • Please enter your first name.
    • Please enter your last name.
    • Please enter your email address.
      This isn't a valid email address.
    • This isn't a valid phone number.
    • Please make a selection.
    • Please enter a message.